Syndax Pharmaceuticals Inc. - 8-K Filing

Syndax Pharmaceuticals Inc. has amended its Amended and Restated Bylaws, effective December 18, 2025. The key change is that all shares of the Company's capital stock will be issued in uncertificated form from this date forward. However, any shares that were already issued in certificated form prior to December 18, 2025, will remain in that format until the certificate is surrendered to the Company. This amendment aims to modernize the stock issuance process.